TTrialPathMatch Me to Trials
← Back to trials
RecruitingObesityOverweightObstructive Sleep Apnoea

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Eligible age

18+ yrs

Accepts

All genders

Locations

9 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with excess body weight and obstructive sleep apnoea not treated with positive airway pressure lose weight and improve sleep apnoea. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111, (the treatment being tested) or Placebo (a treatment that has no active medicine in it) and which treatment participants get is decided by chance.

Sponsor: Novo Nordisk A/S

Where it's recruiting

California

San Diego

Florida

Miami · Naples · Ocala

Georgia

Atlanta · Lawrenceville

Illinois

Chicago

New York

New York

Ohio

Cincinnati

Texas

DeSoto · El Paso · Houston · San Antonio

Source: ClinicalTrials.gov · NCT07571005 · last updated 2026-06-02

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487- · TrialPath